ENTITY
Biogen

Biogen (BIIB UW)

1
Analysis
Health CareUnited States
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company products address diseases such as multiple sclerosis, non-hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.
more
01 Mar 2018 08:44

Will Actinogen Ace Alzheimer's?

Alzheimer’s disease is an incurable neurodegenerative disorder that robs the affected individuals of memory, self-care and quality of life,...

Logo
359 Views
Share
bearishCelltrion Inc
15 Feb 2018 23:24

Biosimilar Battlefield: An Update

Korea's biosimilar plays, Celltrion Inc (068270 KS) , Celltrion Pharm Inc (068760 KS) , Celltrion Healthcare (091990 KS) , and Samsung Biologics...

Share
bullishS&P 500 INDEX
24 Jan 2018 06:51

U.S. Equity Strategy

Our long-term bullish outlook remains intact. The weight of the evidence still points to further upside, allowing, of course, for occasional...

Logo
460 Views
Share
05 Jan 2018 09:35

Human Longevity

At KIS capital we try to keep ourselves at the forefront of technology and innovation, attempting to identify which industries may blossom, and...

Share
08 Nov 2017 20:24

Genomics as an Investment Theme

Genomics as an investment theme Costs of sequencing a human genome have fallen to less than $1,000 China leads the world in gene sequencing The...

Logo
392 Views
Share
x